| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-07 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.25 | 7e-07 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |